| Resistance mechanisms for the Bruton's tyrosine kinase inhibitor ibrutinib JA Woyach, RR Furman, TM Liu, HG Ozer, M Zapatka, AS Ruppert, L Xue, ... New England Journal of Medicine 370 (24), 2286-2294, 2014 | 1334 | 2014 |
| Differential mutation frequencies in metastatic cutaneous squamous cell carcinomas versus primary tumors AS Yilmaz, HG Ozer, JL Gillespie, DC Allain, MN Bernhardt, KC Furlan, ... Cancer 123 (7), 1184-1193, 2017 | 73 | 2017 |
| A new method for stranded whole transcriptome RNA-seq DFB Miller, PS Yan, A Buechlein, BA Rodriguez, AS Yilmaz, S Goel, H Lin, ... Methods 63 (2), 126-134, 2013 | 51 | 2013 |
| Novel BCL2 mutations in venetoclax-resistant, ibrutinib-resistant CLL patients with BTK/PLCG2 mutations F Lucas, K Larkin, CT Gregory, S Orwick, TJ Doong, A Lozanski, ... Blood, The Journal of the American Society of Hematology 135 (24), 2192-2195, 2020 | 48 | 2020 |
| Genomic characterization of non–small-cell lung cancer in African Americans by targeted massively parallel sequencing LH Araujo, C Timmers, EH Bell, K Shilo, PE Lammers, W Zhao, ... Journal of Clinical Oncology 33 (17), 1966, 2015 | 48 | 2015 |
| Somatic mutation spectrum of non–small-cell lung cancer in African Americans: a pooled analysis LH Araujo, PE Lammers, V Matthews-Smith, R Eisenberg, A Gonzalez, ... Journal of Thoracic Oncology 10 (10), 1430-1436, 2015 | 42 | 2015 |
| Prognostic and biological significance of the proangiogenic factor EGFL7 in acute myeloid leukemia D Papaioannou, C Shen, D Nicolet, B McNeil, M Bill, M Karunasiri, ... Proceedings of the National Academy of Sciences 114 (23), E4641-E4647, 2017 | 40 | 2017 |
| MiR-34a regulates the invasive capacity of canine osteosarcoma cell lines CM Lopez, PY Yu, X Zhang, AS Yilmaz, CA London, JM Fenger PLoS One 13 (1), e0190086, 2018 | 32 | 2018 |
| Use of laser capture microdissection for the assessment of equine lamellar basal epithelial cell signalling in the early stages of laminitis BS Leise, MR Watts, S Roy, AS Yilmaz, H Alder, JK Belknap Equine veterinary journal 47 (4), 478-488, 2015 | 32 | 2015 |
| METTL3 regulates liver homeostasis, hepatocyte ploidy, and circadian rhythm–controlled gene expression in mice JM Barajas, CH Lin, HL Sun, F Alencastro, AC Zhu, M Aljuhani, L Navari, ... The American Journal of Pathology 192 (1), 56-71, 2022 | 28 | 2022 |
| Discovery and characterization of the feline miRNAome A Laganà, WP Dirksen, W Supsavhad, AS Yilmaz, HG Ozer, JD Feller, ... Scientific reports 7 (1), 9263, 2017 | 25 | 2017 |
| Targeting squalene epoxidase interrupts homologous recombination via the ER stress response and promotes radiotherapy efficacy Z Hong, T Liu, L Wan, P Fa, P Kumar, Y Cao, CB Prasad, Z Qiu, J Liu, ... Cancer research 82 (7), 1298-1312, 2022 | 23 | 2022 |
| Transcriptional targeting of oncogene addiction in medullary thyroid cancer A Valenciaga, M Saji, L Yu, X Zhang, C Bumrah, AS Yilmaz, CM Knippler, ... JCI insight 3 (16), 2018 | 23 | 2018 |
| Clinical trial links oncolytic immunoactivation to survival in glioblastoma AL Ling, IH Solomon, AM Landivar, H Nakashima, JK Woods, A Santos, ... Nature 623 (7985), 157-166, 2023 | 21 | 2023 |
| BISR-RNAseq: an efficient and scalable RNAseq analysis workflow with interactive report generation VS Gadepalli, HG Ozer, AS Yilmaz, M Pietrzak, A Webb BMC bioinformatics 20, 1-7, 2019 | 21 | 2019 |
| Thyroid Carcinomas That Occur in Familial Adenomatous Polyposis Patients Recurrently Harbor Somatic Variants in APC, BRAF, and KTM2D TT Nieminen, CJ Walker, A Olkinuora, LK Genutis, M O'Malley, PE Wakely, ... Thyroid 30 (3), 380-388, 2020 | 20 | 2020 |
| hsa-miR-9-3p and hsa-miR-9-5p as post-transcriptional modulators of DNA topoisomerase IIα in human leukemia K562 cells with acquired resistance to etoposide EE Kania, J Carvajal-Moreno, VA Hernandez, A English, JL Papa, ... Molecular pharmacology 97 (3), 159-170, 2020 | 16 | 2020 |
| Impact of pre-analytical variables on cancer targeted gene sequencing efficiency LH Araujo, C Timmers, K Shilo, W Zhao, J Zhang, L Yu, TG Natarajan, ... PLoS One 10 (11), e0143092, 2015 | 15 | 2015 |
| Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter’s transformation ZA Hing, JS Walker, EC Whipp, L Brinton, M Cannon, P Zhang, S Sher, ... Nature Communications 14 (1), 97, 2023 | 13 | 2023 |
| Validation of protein arginine methyltransferase 5 (PRMT5) as a candidate therapeutic target in the spontaneous canine model of non-Hodgkin lymphoma SL Sloan, KA Renaldo, M Long, JH Chung, LE Courtney, K Shilo, ... PloS one 16 (5), e0250839, 2021 | 10 | 2021 |
